Where it trades today
trading 34% of the way up its 52-week range
How the price has moved
What to weigh before acting
What Matters Now
- The read on the stock is often driven by pipeline durability, reimbursement pressure, and whether new launches can offset patent cliffs.
- UHS trades at 7.2x earnings versus 22.0x for the sector, which means the rerating case depends on proving the discount is too harsh.
- UHS carries a beta of 1.06, which means the stock should be judged on how it affects total portfolio swings, not just on standalone upside.
- Relative performance versus UNH, JNJ, PFE matters here because leadership inside healthcare rarely stays static for long.
Portfolio Use Case
- UHS is more useful for investors comparing conviction names inside healthcare than for someone looking for a passive “set and forget” holding.
- The risk profile looks balanced enough for a diversified core-plus portfolio, provided the position size reflects sector concentration.
- The stock becomes more useful when paired with an explicit catalyst watchlist, because sector sentiment can shift quickly around policy, rates, or pipeline news.
What Would Change the View
- Volatility is already above the sector norm, so even a correct long-term thesis can be painful if the position size is too aggressive.
- The view would need revisiting if peers such as UNH, JNJ, PFE start winning the marginal flow or posting cleaner operating momentum.
Methodology
- Price, market cap, beta, yield, and liquidity fields for UHS come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Healthcare so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as UNH, JNJ, PFE.
Sources
- Yahoo Finance quote dataopen →
Live quote, valuation, beta, yield, and volume fields used for UHS. Last refresh: Sep 18, 2026, 10:57 PM.
- Portfolio Terminal methodologyopen →
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
- Peer set and coverage context
Comparative context for this page is anchored around nearby tracked names such as UNH, JNJ, PFE.
What Universal Health Services does
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning,…
Employees
102,000
Industry
Medical Care Facilities
Headquarters
King of Prussia, United States
What analysts expect
UHS carries a buy consensus from 17 analysts, with an average price target of $193.94 versus $176.69 today (+9.8%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
UHS generated $18.11B in trailing revenue (8.3% year over year), with a 8.4% net margin, and $498.32M of free cash flow, against $5.12B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $17.36B | $15.71B | $1.99B | $1.49B | $23.42 | $824.55M |
| 2024 | $15.83B | $14.24B | $1.68B | $1.14B | $17.16 | $1.12B |
| 2023 | $14.28B | $12.75B | $1.18B | $717.79M | $10.35 | $524.74M |
| 2022 | $13.40B | $11.93B | $1.00B | $675.61M | $9.23 | $262.02M |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
How it sits in healthcare
Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.
The companies it competes with
UHS beside the healthcare names it is usually measured against.
What the chart is saying
Universal Health Services trades at $176.69, 28.3% below its 52-week high. With a beta of 1.06, it shows about average sensitivity to what the wider market does.
Questions people ask about it
Is UHS a good buy right now?
Universal Health Services trades at 7.2x earnings. This is below market average, potentially undervalued. Current risk level is Medium based on 25.0% volatility.
Does UHS pay dividends?
Yes, Universal Health Services offers a dividend yield of 0.44%. That is roughly $0.78 per share a year.
How volatile is UHS?
With 30-day annualized volatility of 25.0% and beta of 1.06, UHS is classified as Medium risk. Expect larger swings than the broader market during volatile periods.
What is the analyst price target for UHS?
The average analyst price target for Universal Health Services (UHS) is $193.94 based on 17 analyst estimates, about 9.8% above the current price of $176.69. The published range runs from $166.00 to $290.00.
How much revenue does UHS generate?
Universal Health Services reported $18.11B in trailing twelve-month revenue. Revenue growth is running at 8.3% year over year. Net margin sits at 8.4%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.